SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5,878.52 |
| Enterprise Value ($M) | 5,396.52 |
| Book Value ($M) | 662.00 |
| Book Value / Share | 4.19 |
| Price / Book | 8.88 |
| NCAV ($M) | 295.00 |
| NCAV / Share | 1.87 |
| Price / NCAV | 19.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.13 |
| Return on Assets (ROA) | -0.12 |
| Return on Equity (ROE) | -1.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.83 |
| Current Ratio | 8.93 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,714.00 |
| Assets | 3,081.00 |
| Liabilities | 2,419.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Bb Biotech Ag | 5.00 | -8.61 | |
| 13G/A | T. Rowe Price Investment Management, Inc. | 9.00 | 7.32 | |
| 13G | Wellington Management Group Llp | 5.76 | 34.37 | |
| 13G/A | Vanguard Group Inc | 9.90 | -1.47 | |
| 13G/A | Fmr Llc | 15.00 | 1.00 | |
| 13G/A | BlackRock, Inc. | 6.30 | -1.37 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 383,147 | 1,512,650 | 25.33 | |
| 427,138 | 1,516,270 | 28.17 | |
| 238,879 | 769,499 | 31.04 | |
| 179,854 | 753,036 | 23.88 | |
| 87,008 | 568,398 | 15.31 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INVA – Innoviva, Inc. | INZY – Inozyme Pharma, Inc. |
| IOBT – IO Biotech, Inc. | IPSC – Century Therapeutics, Inc. |
| IRWD – Ironwood Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io